We are live on ! Find out more
VHAQ.WS

Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS

Delisted

VHAQ.WS was delisted on the 23rd of October, 2023.

28 hedge funds and large institutions have $12.3M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

11% more capital invested

Capital invested by funds: $11.1M → $12.3M (+$1.22M)

4% more funds holding

Funds holding: 2728 (+1)

88% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 8

Holders
28
Holders Change
+1
Holders Change %
+3.7%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
1
Reduced
8
Closed
5
Calls
$801K
Puts
Net Calls
+$801K
Net Calls Change
+$801K

VHAQ.WS Hedge Fund Activity: Q2 2021 in Review

28 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q2 2021, worth a combined $12.3M — up 11% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VHAQ.WS positions and 5 closed out — a net gain of 1 holder — while 1 added to existing stakes and 8 trimmed.

The largest buyer was Linden Advisors, adding an estimated $306K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $306K sold.

  • 28 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q2 2021, up from 27 in Q1 2021.
  • Funds reported $12.3M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q2 2021, up 11% quarter-over-quarter.
  • 6 funds opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q2 2021 and 5 closed out, a net change of +1 holder.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q2 2021 was Linden Advisors, an estimated $306K added.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q2 2021 was K2 Principal Fund, an estimated $306K sold.

Based on aggregated 13F filings for Q2 2021.